Rocket Pharmaceuticals in-27RCKTWPreferred / convertible
13F holders, Q2 2025 (June 30)12holders −1
0new positions
1sold out
1famous investor
$0.08avg. 13F price*
At the end of Q2 2025, 12 institutions reported holding Rocket Pharmaceuticals in-27 (RCKTW) in their 13F filings, down 1 from Q1 2025. 0 opened new positions and 1 sold out. The largest holders were Boothbay Fund Management, LLC ($90K), Walleye Capital LLC ($25K) and Sio Capital Management, LLC ($14K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Rocket Pharmaceuticals in-27
- CUSIP
- 77313F114
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $5 |
All 13F filers, Q1 2025 → Q2 2025: 130,923 shares sold, net −130,923 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Boothbay Fund Management, LLC | — | No change | 36,912 | $90K |
| Walleye Capital LLC | — | Reduce -3.5% | 642,847 | $25K |
| Sio Capital Management, LLC | — | No change | 400,000 | $14K |
| RTW Investments, LP | — | No change | 350,000 | $10K |
| Citadel Advisors | — | Reduce -0.8% | 314,842 | $9K |
| Silverarc Capital Management, LLC | — | No change | 104,828 | $3K |
| LMR Partners LLP | — | No change | 75,731 | $3K |
| Walleye Trading LLC | — | Reduce -24.5% | 63,391 | $2K |
| Affinity Asset Advisors, LLC | — | No change | 75,000 | $2K |
| Susquehanna International Group, LLP | — | Reduce -64.5% | 42,559 | $2K |
| Ancora Advisors LLC | — | No change | 6,000 | $204 |
| Virtu Financial LLC | — | Reduce -38.8% | 11,402 | $0 |
"% of holder's portfolio" is RCKTW's weight in each manager's 13F, not the share of Rocket Pharmaceuticals in-27 the manager owns.